LGR6 and diabetic kidney disease: Our study demonstrates that decreased serum MaR1 levels were positively correlated with the development of DKD and MaR1 injection up-regulated the expression of its receptor, LGR6, and then alleviates DKD via LGR6-mediated cAMP-SOD2 antioxidant pathway.